Microbe‐associated metabolites as targets for incident type 2 diabetes

Metabolites produced by gut microbiota could be pathogenic or beneficial to the host. Gut microbiota varies among countries, age and sex, there is a possibility that the microbe‐associated metabolites might vary among countries, age and sex. Further studies are required to clarify the relationship a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Yoshitaka, Hamaguchi, Masahide, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015822/
https://www.ncbi.nlm.nih.gov/pubmed/33006816
http://dx.doi.org/10.1111/jdi.13424
_version_ 1783673752977932288
author Hashimoto, Yoshitaka
Hamaguchi, Masahide
Fukui, Michiaki
author_facet Hashimoto, Yoshitaka
Hamaguchi, Masahide
Fukui, Michiaki
author_sort Hashimoto, Yoshitaka
collection PubMed
description Metabolites produced by gut microbiota could be pathogenic or beneficial to the host. Gut microbiota varies among countries, age and sex, there is a possibility that the microbe‐associated metabolites might vary among countries, age and sex. Further studies are required to clarify the relationship among diet, gut microbiota, gut microbiota‐related metabolites and development of type 2 diabetes.[Image: see text]
format Online
Article
Text
id pubmed-8015822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80158222021-04-02 Microbe‐associated metabolites as targets for incident type 2 diabetes Hashimoto, Yoshitaka Hamaguchi, Masahide Fukui, Michiaki J Diabetes Investig Commentaries Metabolites produced by gut microbiota could be pathogenic or beneficial to the host. Gut microbiota varies among countries, age and sex, there is a possibility that the microbe‐associated metabolites might vary among countries, age and sex. Further studies are required to clarify the relationship among diet, gut microbiota, gut microbiota‐related metabolites and development of type 2 diabetes.[Image: see text] John Wiley and Sons Inc. 2020-11-09 2021-04 /pmc/articles/PMC8015822/ /pubmed/33006816 http://dx.doi.org/10.1111/jdi.13424 Text en © 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Commentaries
Hashimoto, Yoshitaka
Hamaguchi, Masahide
Fukui, Michiaki
Microbe‐associated metabolites as targets for incident type 2 diabetes
title Microbe‐associated metabolites as targets for incident type 2 diabetes
title_full Microbe‐associated metabolites as targets for incident type 2 diabetes
title_fullStr Microbe‐associated metabolites as targets for incident type 2 diabetes
title_full_unstemmed Microbe‐associated metabolites as targets for incident type 2 diabetes
title_short Microbe‐associated metabolites as targets for incident type 2 diabetes
title_sort microbe‐associated metabolites as targets for incident type 2 diabetes
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015822/
https://www.ncbi.nlm.nih.gov/pubmed/33006816
http://dx.doi.org/10.1111/jdi.13424
work_keys_str_mv AT hashimotoyoshitaka microbeassociatedmetabolitesastargetsforincidenttype2diabetes
AT hamaguchimasahide microbeassociatedmetabolitesastargetsforincidenttype2diabetes
AT fukuimichiaki microbeassociatedmetabolitesastargetsforincidenttype2diabetes

Ejemplares similares